← Evidence map

ArticleMolecular therapy. Oncology2024

Muc16CD is a novel CAR T cell target antigen for the treatment of pancreatic cancer.

Heather K Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

5 papers cite it

2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 39346763